These data reflected that Oxysophocarpine decreased FGL1 expression through downregulating IL‐6‐mediated JAK2/STAT3 signal pathway in HCC cells and subsequently sensitize anti‐Lag3 therapeutic effect. This evidence concerns the gene STAT3 and hepatocellular carcinoma.